Market Cap
Low in industry
PE TTM
Negative PE TTM
PEG TTM
Price to Book
Beta 1Year
Very Low volatility
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Maria Carolina Petrini | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 400,000 | 400,000 | - | - | Nonqualified Stock Option (Right to Buy) | |
Robert B. Geller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Leonard Scott Dove | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Rudy Howard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 135,884 | 135,884 | - | - | Series A Warrants (right to buy) | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 135,884 | 135,884 | - | - | Series B Warrants (right to buy) | |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 271,769 | 271,769 | - | - | Series A Warrants (right to buy) | |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 543,537 | 1,403,303 (9%) | 3% | 0.9 | 500,000 | Common stock |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 271,768 | 271,768 | - | - | Series B Warrants (right to buy) | |
Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 8,153,060 | 8,153,060 | - | - | Series B Warrants (right to buy) | |
Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 16,306,120 | 25,517,889 (170%) | 109% | 0.9 | 15,000,000 | Common Stock |
Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 8,153,060 | 8,153,060 | - | - | Series A Warrants (right to buy) | |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 54,353 | 65,490 (0%) | 0% | 0.9 | 49,999 | Common stock |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 27,176 | 27,176 | - | - | Series B Warrants (right to buy) | |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 27,177 | 27,177 | - | - | Series A Warrants (right to buy) | |
Rudy Howard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 5,435 | 5,435 | - | - | Series B Warrants (right to buy) | |
Rudy Howard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 10,870 | 10,870 (0%) | 0% | 0.9 | 9,999 | Common stock |
Rudy Howard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 5,435 | 5,435 | - | - | Series A Warrants (right to buy) | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 271,768 | 1,213,648 (8%) | 1% | 0.9 | 249,999 | Common stock |
Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
John A. Hohneker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
Sigurd C. Kirk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
Robert B. Geller | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 200,000 | 200,000 | - | - | Stock Option | |
Rudy Howard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 290,000 | 290,000 | - | - | Stock Option | |
Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,545,455 | 9,211,769 (61%) | 30% | 0.0 | 455 | Common Stock |
Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,545,455 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 860,216 | 860,216 | - | - | Warrant (right to buy) | |
Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.32 per share. | 29 Mar 2022 | 860,216 | 4,666,314 (31%) | 5% | 2.3 | 2,000,002 | Common Stock |
Leonard Scott Dove | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to buy) | |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 425,000 | 425,000 | - | - | Stock Option (Right to buy) | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to buy) | |
Reshma Rangwala | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to buy) | |
Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,545,455 | 4,545,455 | - | - | Pre-Funded Warrant (right to buy) | |
Amato Giaccia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2021 | 48,366 | 941,880 (6%) | 0% | 0 | Common Stock | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 500 | 8,620 | - | - | Stock Option | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 38,761 | 0 | - | - | Stock Option | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 12,350 | 0 | - | - | Stock Option | |
Amato Giaccia | Director | Sale of securities on an exchange or to another person at price $ 3.23 per share. | 30 Nov 2021 | 39 | 990,246 (6%) | 0% | 3.2 | 126 | Common Stock |
Amato Giaccia | Director | Sale of securities on an exchange or to another person at price $ 3.22 per share. | 30 Nov 2021 | 2,954 | 990,285 (6%) | 0% | 3.2 | 9,512 | Common Stock |
Amato Giaccia | Director | Sale of securities on an exchange or to another person at price $ 3.22 per share. | 30 Nov 2021 | 252 | 993,239 (6%) | 0% | 3.2 | 811 | Common Stock |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 30 Nov 2021 | 500 | 993,491 (6%) | 0% | 0.2 | 120 | Common Stock |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 30 Nov 2021 | 38,761 | 992,991 (6%) | 0% | 0.2 | 9,303 | Common Stock |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.06 per share. | 30 Nov 2021 | 12,350 | 954,230 (6%) | 0% | 0.1 | 741 | Common Stock |
Fredric N. Eshelman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
Sigurd C. Kirk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
John A. Hohneker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
Sigurd C. Kirk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,245 | 5,245 | - | - | Stock Options | |
Sigurd C. Kirk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 15,435 | 15,435 | - | - | Stock Options | |
John A. Hohneker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 5,245 | 5,245 | - | - | Stock Options | |
John A. Hohneker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 15,435 | 15,435 | - | - | Stock Options | |
Gail McIntyre | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 5.34 per share. | 29 Jun 2021 | 1,000 | 11,137 (0%) | 0% | 5.3 | 5,345 | Common Stock |
Vinay Shah | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 29 Jun 2021 | 1,000 | 190,842 (1%) | 0% | 5.3 | 5,310 | Common Stock |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 4,028 | 0 | - | - | Stock Option (Right to buy) | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 8,055 | 0 | - | - | Stock Option (Right to buy) | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.06 per share. | 19 Mar 2021 | 8,055 | 949,935 (6%) | 0% | 0.1 | 483 | Common Stock |
Amato Giaccia | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Mar 2021 | 12,083 | 941,880 (6%) | 0% | 0 | Common Stock | |
Amato Giaccia | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.06 per share. | 19 Mar 2021 | 4,028 | 953,963 (6%) | 0% | 0.1 | 242 | Common Stock |
Fredric N. Eshelman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.29 per share. | 12 Feb 2021 | 2,875,000 | 3,806,098 (25%) | 19% | 7.3 | 20,958,750 | Common stock |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 165,000 | 165,000 | - | - | Stock Options | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 60,000 | 60,000 | - | - | Stock Options | |
Reshma Rangwala | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 10,000 | 10,000 | - | - | Stock Options | |
Reshma Rangwala | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 75,000 | 75,000 | - | - | Stock Option | |
Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 14,987 | 14,987 | - | - | Stock Option | |
Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 15,024 | 15,024 | - | - | Stock Option | |
Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 16,029 | 16,029 | - | - | Stock Option | |
Amato Giaccia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 16,029 | 16,029 | - | - | Stock Option | |
Raymond Tabibiazar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 16,029 | 16,029 | - | - | Stock Option | |
Eric Zhang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 16,029 | 16,029 | - | - | Stock Option | |
Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 7,500 | 7,500 | - | - | Stock Option | |
Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 3,226 | 3,226 | - | - | Stock Option | |
Jay P. Shepard | Former Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Apr 2020 | 9,291 | 61,201 (0%) | 0% | 0 | Common Stock | |
Gail McIntyre | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2020 | 80,000 | 80,000 | - | - | Stock Option | |
Rekha Hemrajani | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Apr 2020 | 42,750 | 14,250 (0%) | 0% | 0 | Common Stock | |
Gail McIntyre | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2020 | 48,583 | 48,583 | - | - | Stock Option | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2020 | 34,826 | 34,826 | - | - | Stock Option | |
Jay P. Shepard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2020 | 5,075 | 5,075 | - | - | Stock Option | |
Rekha Hemrajani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2020 | 57,000 | 57,000 (0%) | 0% | 0 | Common Stock | |
Rekha Hemrajani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2020 | 143,000 | 143,000 | - | - | Stock Options | |
Jay P. Shepard | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.67 per share. | 20 Dec 2019 | 2,262 | 70,492 (0%) | 0% | 11.7 | 26,398 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 7.50 per share. | 02 Dec 2019 | 133,333 | 576,066 (3%) | 0% | 7.5 | 999,998 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.82 per share. | 07 Oct 2019 | 4,004 | 72,754 (0%) | 0% | 6.8 | 27,295 | Common Stock |
Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Eric Zhang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 10 May 2019 | 1,192 | 76,758 (0%) | 0% | 6.1 | 7,283 | Common Stock |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 116,000 | 116,000 | - | - | Stock Option | |
Gail McIntyre | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 53,000 | 53,000 | - | - | Stock Option | |
Kevin Haas | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 18,000 | 18,000 | - | - | Stock Option | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 38,000 | 38,000 | - | - | Stock Option | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 01 Feb 2019 | 204 | 83,909 (0%) | 0% | 4.1 | 845 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 01 Feb 2019 | 990 | 81,950 (0%) | 0% | 4.1 | 4,099 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 01 Feb 2019 | 969 | 82,940 (0%) | 0% | 4.1 | 4,012 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 01 Feb 2019 | 63 | 10,933 (0%) | 0% | 4.1 | 261 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 4.14 per share. | 01 Feb 2019 | 141 | 10,996 (0%) | 0% | 4.1 | 584 | Common Stock |
Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Eric Zhang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 4,688 | 4,688 | - | - | Stock Option | |
Eric Zhang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2019 | 7,500 | 7,500 | - | - | Stock Option | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.22 per share. | 21 Dec 2018 | 3,484 | 84,113 (0%) | 0% | 3.2 | 11,232 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.22 per share. | 21 Dec 2018 | 686 | 11,162 (0%) | 0% | 3.2 | 2,207 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 21 Dec 2018 | 25 | 11,137 (0%) | 0% | 3.2 | 81 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 17 Dec 2018 | 11,247 | 87,597 (0%) | 0% | 4.0 | 44,561 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 17 Dec 2018 | 1,164 | 11,848 (0%) | 0% | 4.0 | 4,612 | Common Stock |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 27,456 | 31,815 (0%) | 0% | 0 | Common Stock | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 38,001 | 38,001 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,000 | 19,000 | - | - | Stock Option (RIght to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 941,880 | 941,880 (15%) | 15% | 0 | Common Stock | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 4,028 | 4,028 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 8,055 | 8,055 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 12,350 | 12,350 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 38,761 | 38,761 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 26,813 | 26,813 | - | - | Stock Option (Right to Buy) | |
Amato Giaccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 9,120 | 9,120 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 1,000,751 | 1,000,751 (16%) | 16% | 0 | Common Stock | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 46,322 | 46,322 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 12,084 | 12,084 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 51,682 | 51,682 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 65,365 | 65,365 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 254,177 | 254,177 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 57,002 | 57,002 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 28,501 | 28,501 | - | - | Stock Option (Right to Buy) | |
Raymond Tabibiazar | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 28,501 | 28,501 | - | - | Stock Option (Right to Buy) | |
Eric Zhang | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 859,766 | 859,766 (14%) | 14% | 0 | Common Stock | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,380 | 19,380 | - | - | Stock Option (Right to Buy) | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 38,001 | 38,001 | - | - | Stock Option (Right to Buy) | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 178,606 | 178,606 (2%) | 2% | 0 | Common Stock | |
Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 15 Jun 2018 | 612 | 225,124 (0%) | 0% | 2.3 | 1,408 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 15 Jun 2018 | 143 | 78,075 (0%) | 0% | 2.3 | 329 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 13 Jun 2018 | 53,018 | 2,682,554 (7%) | 0% | 2.1 | 112,928 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 06 Jun 2018 | 660,681 | 2,234,732 (6%) | 1% | 1.7 | 1,149,585 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 06 Jun 2018 | 163,224 | 2,397,956 (6%) | 0% | 1.8 | 301,964 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 06 Jun 2018 | 231,580 | 2,629,536 (7%) | 0% | 2 | 463,160 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 22 May 2018 | 9,232 | 593,066 (1%) | 0% | 1.5 | 13,848 | Common Stock |
Jay S. Stout | SVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 24 Apr 2018 | 4,854 | 185,646 (0%) | 0% | 1.6 | 7,524 | Common Stock |
Tracy M. Woody | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 23 Mar 2018 | 4,345 | 215,755 (0%) | 0% | 1.8 | 7,604 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2018 | 14,446 | 602,298 (1%) | 0% | 1.8 | 26,003 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2018 | 5,355 | 225,736 (0%) | 0% | 1.8 | 9,639 | Common Stock |
Shane M. Ward | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2018 | 4,118 | 201,556 (0%) | 0% | 1.8 | 7,412 | Common Stock |
Kevin Haas | VP, Finance and PAO | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 08 Feb 2018 | 1,599 | 78,218 (0%) | 0% | 1.8 | 2,878 | Common Stock |
Eric L. Dobmeier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 18,160 (0%) | 0% | 0 | Common Stock | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 44,380 (0%) | 0% | 0 | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 26,155 (0%) | 0% | 0 | Common Stock | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 22,380 (0%) | 0% | 0 | Common Stock | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 223,000 | 616,744 (1%) | 0% | 0 | Common Stock | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 22,280 (0%) | 0% | 0 | Common Stock | |
Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 23,880 (0%) | 0% | 0 | Common Stock | |
Paul Westberg | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 90,900 | 231,091 (0%) | 0% | 0 | Common Stock | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 11,200 | 23,880 (0%) | 0% | 0 | Common Stock | |
Tracy M. Woody | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 93,100 | 220,100 (0%) | 0% | 0 | Common Stock | |
Shane M. Ward | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 93,100 | 205,674 (0%) | 0% | 0 | Common Stock | |
Jay S. Stout | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 74,500 | 190,500 (0%) | 0% | 0 | Common Stock | |
Robert Gut | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 91,300 | 227,300 (0%) | 0% | 0 | Common Stock | |
Kevin Haas | VP, Finance and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2017 | 44,700 | 79,817 (0%) | 0% | 0 | Common Stock | |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 01 Dec 2017 | 419,700 | 991,129 (2%) | 1% | 2.1 | 893,961 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 01 Dec 2017 | 513,872 | 1,505,001 (4%) | 1% | 2.2 | 1,135,657 | Common Stock |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 01 Dec 2017 | 42,895 | 1,547,896 (4%) | 0% | 2 | 85,790 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2017 | 15,000 | 140,191 (0%) | 0% | 0 | Common Stock | |
Shane M. Ward | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2017 | 20,000 | 112,574 (0%) | 0% | 0 | Common Stock | |
Colin Hislop | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 19 Oct 2017 | 667 | 23,833 (0%) | 0% | 2.6 | 1,701 | Common Stock |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 19 Oct 2017 | 1,326 | 201,269 (0%) | 0% | 2.5 | 3,381 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 19 Oct 2017 | 1,326 | 125,191 (0%) | 0% | 2.5 | 3,381 | Common Stock |
Shane M. Ward | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 19 Oct 2017 | 776 | 92,574 (0%) | 0% | 2.6 | 1,979 | Common Stock |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 189,000 | 393,744 (1%) | 0% | 0 | Common Stock | |
Joshua T. Brumm | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 97,000 | 202,595 (0%) | 0% | 0 | Common Stock | |
Paul Westberg | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 59,000 | 126,517 (0%) | 0% | 0 | Common Stock | |
Tracy M. Woody | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 82,000 | 127,000 (0%) | 0% | 0 | Common Stock | |
Shane M. Ward | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 57,000 | 93,350 (0%) | 0% | 0 | Common Stock | |
Jay S. Stout | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 70,000 | 116,000 (0%) | 0% | 0 | Common Stock | |
Robert Gut | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2017 | 88,000 | 136,000 (0%) | 0% | 0 | Common Stock | |
Robert Gut | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2017 | 107,000 | 107,000 | - | - | Stock Option (Right to Buy) | |
Robert Gut | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2017 | 48,000 | 48,000 (0%) | 0% | 0 | Common Stock | |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 13 Jun 2017 | 1,421 | 105,595 (0%) | 0% | 16.0 | 22,807 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 13 Jun 2017 | 711 | 67,517 (0%) | 0% | 16.1 | 11,412 | Common Stock |
Eric L. Dobmeier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
Eric L. Dobmeier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 3,480 (0%) | 0% | 0 | Common Stock | |
Eric L. Dobmeier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 6,960 (0%) | 0% | 0 | Common Stock | |
Eric L. Dobmeier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 33,180 (0%) | 0% | 0 | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 14,955 (0%) | 0% | 0 | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 11,180 (0%) | 0% | 0 | Common Stock | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 11,080 (0%) | 0% | 0 | Common Stock | |
Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 12,680 (0%) | 0% | 0 | Common Stock | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 6,850 | 6,850 | - | - | Stock Option (Right to Buy) | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2017 | 3,480 | 12,680 (0%) | 0% | 0 | Common Stock | |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 17.40 per share. | 16 May 2017 | 1,263 | 107,016 (0%) | 0% | 17.4 | 21,976 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 11 May 2017 | 9,114 | 204,744 (0%) | 0% | 17.5 | 159,495 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 19.85 per share. | 19 Apr 2017 | 1,316 | 68,228 (0%) | 0% | 19.9 | 26,123 | Common Stock |
Colin Hislop | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.17 per share. | 04 Apr 2017 | 35,000 | 59,500 (0%) | 0% | 8.2 | 285,950 | Common Stock |
Colin Hislop | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 04 Apr 2017 | 35,000 | 24,500 (0%) | 0% | 21.2 | 742,000 | Common Stock |
Colin Hislop | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2017 | 35,000 | 188,100 | - | - | Stock Option (Right to Buy) | |
Jay S. Stout | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Jay S. Stout | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2017 | 45,000 | 46,000 (0%) | 0% | 0 | Common Stock | |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 12.25 per share. | 24 Mar 2017 | 571,429 | 571,429 (1%) | 1% | 12.2 | 7,000,005 | Common Stock |
Tracy M. Woody | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2017 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Tracy M. Woody | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2017 | 45,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 16 Mar 2017 | 97,303 | 2,007,925 (5%) | 0% | 18.5 | 1,800,106 | Common Stock |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 16 Mar 2017 | 386,367 | 1,621,558 (4%) | 1% | 18.0 | 6,958,470 | Common Stock |
Shane M. Ward | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 14 Mar 2017 | 1,265 | 37,126 (0%) | 0% | 19 | 24,035 | Common Stock |
Shane M. Ward | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 19.02 per share. | 14 Mar 2017 | 776 | 36,350 (0%) | 0% | 19.0 | 14,760 | Common Stock |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 19.42 per share. | 13 Mar 2017 | 16,330 | 2,255,228 (6%) | 0% | 19.4 | 317,129 | Common Stock |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 13 Mar 2017 | 100 | 2,255,128 (6%) | 0% | 19.0 | 1,903 | Common Stock |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 13 Mar 2017 | 46,778 | 2,208,350 (6%) | 0% | 19 | 888,782 | Common Stock |
Shahzad Malik | None | Sale of securities on an exchange or to another person at price $ 19.08 per share. | 13 Mar 2017 | 103,122 | 2,105,228 (6%) | 0% | 19.1 | 1,967,568 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 27 Feb 2017 | 5,166 | 219,024 (0%) | 0% | 2.5 | 13,070 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2017 | 5,166 | 65,828 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 27 Feb 2017 | 5,166 | 213,858 (0%) | 0% | 24 | 123,984 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 27 Feb 2017 | 4,991 | 82,044 (0%) | 0% | 2.5 | 12,627 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 27 Feb 2017 | 7,509 | 77,053 (0%) | 0% | 1.6 | 12,089 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2017 | 7,509 | 2,975 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2017 | 4,991 | 7,491 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 27 Feb 2017 | 12,500 | 69,544 (0%) | 0% | 22.5 | 281,250 | Common Stock |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 21.46 per share. | 24 Feb 2017 | 6,008 | 111,432 (0%) | 0% | 21.5 | 128,932 | Common Stock |
Joshua T. Brumm | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2017 | 30,000 | 122,108 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 24 Feb 2017 | 30,000 | 135,779 (0%) | 0% | 2.5 | 75,900 | Common Stock |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 20.42 per share. | 24 Feb 2017 | 18,339 | 117,440 (0%) | 0% | 20.4 | 374,482 | Common Stock |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 22.05 per share. | 24 Feb 2017 | 5,653 | 105,779 (0%) | 0% | 22.1 | 124,649 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2017 | 8,000 | 70,994 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 21 Feb 2017 | 8,000 | 213,858 (0%) | 0% | 20 | 160,000 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 21 Feb 2017 | 8,000 | 221,858 (0%) | 0% | 2.5 | 20,240 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 21 Feb 2017 | 8,000 | 213,858 (0%) | 0% | 18.5 | 148,000 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 21 Feb 2017 | 8,000 | 221,858 (0%) | 0% | 2.5 | 20,240 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2017 | 8,000 | 78,994 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 21 Feb 2017 | 6,590 | 76,134 (0%) | 0% | 1.6 | 10,610 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 21 Feb 2017 | 5,910 | 69,544 (0%) | 0% | 20 | 118,200 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 21 Feb 2017 | 12,500 | 75,454 (0%) | 0% | 17.5 | 218,750 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 21 Feb 2017 | 18,410 | 87,954 (0%) | 0% | 1.6 | 29,640 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 21 Feb 2017 | 6,590 | 69,544 (0%) | 0% | 20 | 131,800 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2017 | 15,087 | 506 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2017 | 3,323 | 17,074 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | SVP and Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2017 | 6,590 | 10,484 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 03 Feb 2017 | 6,719 | 213,858 (0%) | 0% | 13.7 | 91,983 | Common Stock |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 144,900 | 144,900 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.31 per share. | 27 Jan 2017 | 10,596 | 223,384 (0%) | 0% | 13.3 | 141,033 | Common Stock |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.53 per share. | 27 Jan 2017 | 10,596 | 233,980 (0%) | 0% | 2.5 | 26,808 | Common Stock |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 27 Jan 2017 | 6,674 | 223,384 (0%) | 0% | 13.9 | 92,435 | Common Stock |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 10,000 | 230,058 (0%) | 0% | 0 | Common Stock | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 64,700 | 220,058 (0%) | 0% | 0 | Common Stock | |
Jay P. Shepard | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2017 | 10,596 | 108,398 | - | - | Stock Option (Right to Buy) | |
Colin Hislop | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 19,500 | 24,500 (0%) | 0% | 0 | Common Stock | |
Colin Hislop | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 43,700 | 43,700 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 43,900 | 108,724 (0%) | 0% | 0 | Common Stock | |
Joshua T. Brumm | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 65,590 | 65,590 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | COO and CFO | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 27 Jan 2017 | 2,945 | 105,779 (0%) | 0% | 13.9 | 40,794 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 26,860 | 71,460 (0%) | 0% | 0 | Common Stock | |
Paul Westberg | SVP and Chief Business Officer | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 27 Jan 2017 | 1,916 | 69,544 (0%) | 0% | 13.9 | 26,540 | Common Stock |
Paul Westberg | SVP and Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 40,130 | 40,130 | - | - | Stock Option (Right to Buy) | |
Shane M. Ward | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 46,200 | 46,200 | - | - | Stock Option (Right to Buy) | |
Shane M. Ward | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2017 | 20,600 | 39,865 (0%) | 0% | 0 | Common Stock | |
Shane M. Ward | SVP and General Counsel | Sale of securities on an exchange or to another person at price $ 13.85 per share. | 27 Jan 2017 | 1,474 | 38,391 (0%) | 0% | 13.9 | 20,418 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2017 | 11,044 | 10,467 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2017 | 2,312 | 0 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2017 | 10,467 | 0 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2017 | 7,931 | 15,593 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2017 | 746 | 23,524 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 15.66 per share. | 09 Jan 2017 | 11,213 | 44,600 (0%) | 0% | 15.7 | 175,596 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.38 per share. | 09 Jan 2017 | 10,467 | 55,067 (0%) | 0% | 1.4 | 14,444 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 09 Jan 2017 | 746 | 55,813 (0%) | 0% | 1.6 | 1,201 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 15.93 per share. | 09 Jan 2017 | 13,356 | 44,600 (0%) | 0% | 15.9 | 212,761 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.38 per share. | 09 Jan 2017 | 11,044 | 57,956 (0%) | 0% | 1.4 | 15,241 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.27 per share. | 09 Jan 2017 | 2,312 | 46,912 (0%) | 0% | 1.3 | 2,925 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 09 Jan 2017 | 7,931 | 52,531 (0%) | 0% | 1.6 | 12,769 | Common Stock |
Paul Westberg | Sr. VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 09 Jan 2017 | 7,931 | 44,600 (0%) | 0% | 15.2 | 120,868 | Common Stock |
Joshua T. Brumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 990 | 64,824 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Dec 2016 | 361 | 44,600 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2016 | 5,000 | 2,312 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Corporate Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2016 | 5,000 | 49,961 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Corporate Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Dec 2016 | 5,000 | 44,961 | - | - | Common Stock | |
Edmon Jennings | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 08 Dec 2016 | 1,500 | 7,700 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Dec 2016 | 3,021 | 65,814 | - | - | Common Stock | |
Colin Hislop | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2016 | 5,000 | 5,000 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2016 | 10,000 | 68,835 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Corporate Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2016 | 10,000 | 44,961 | - | - | Common Stock | |
Shane M. Ward | SVP, Legal and Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2016 | 5,000 | 19,265 | - | - | Common Stock | |
Srinivas Akkaraju | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Oct 2016 | 571,429 | 571,429 | - | - | Common Stock | |
John Varian | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Aug 2016 | 1,600 | 7,600 | - | - | Common Stock | |
Jay P. Shepard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 22 Aug 2016 | 5,442 | 155,358 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2016 | 1,448 | 58,835 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2016 | 725 | 34,961 | - | - | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2016 | 28,720 | 28,720 | - | - | Stock Option (Right to Buy) | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2016 | 6,900 | 11,475 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 20 May 2016 | 1,265 | 60,283 | - | - | Common Stock | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 4,625 | 29,700 | - | - | Common Stock | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 4,625 | 9,200 | - | - | Common Stock | |
Shahzad Malik | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
Shahzad Malik | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 4,625 | 9,200 | - | - | Common Stock | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 4,625 | 9,200 | - | - | Common Stock | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2016 | 4,625 | 9,200 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Apr 2016 | 1,430 | 35,686 | - | - | Common Stock | |
Colin Hislop | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2016 | 223,100 | 223,100 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 209,200 | 209,200 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 64,800 | 160,800 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 83,800 | 83,800 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 26,000 | 61,548 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 54,400 | 54,400 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 16,900 | 37,116 | - | - | Common Stock | |
Shane M. Ward | SVP, Legal and Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
Shane M. Ward | SVP, Legal and Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2016 | 13,000 | 14,265 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Dec 2015 | 990 | 35,548 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Dec 2015 | 362 | 20,216 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Nov 2015 | 2,500 | 36,538 | - | - | Common Stock | |
R. Scott Greer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Nov 2015 | 300 | 15,375 | - | - | Common Stock | |
R. Scott Greer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Nov 2015 | 200 | 15,575 | - | - | Common Stock | |
R. Scott Greer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Nov 2015 | 9,500 | 25,075 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2015 | 2,400 | 7,312 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Aug 2015 | 2,400 | 22,978 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Aug 2015 | 2,258 | 20,720 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Aug 2015 | 142 | 20,578 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2015 | 2,400 | 9,712 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2015 | 2,400 | 22,978 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Jul 2015 | 2,400 | 20,578 | - | - | Common Stock | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 15,075 | - | - | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 4,575 | - | - | Common Stock | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 4,575 | - | - | Common Stock | |
Shahzad Malik | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
Shahzad Malik | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 4,575 | - | - | Common Stock | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 4,575 | - | - | Common Stock | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 13,100 | 13,100 | - | - | Stock Option (Right to Buy) | |
Anthony Y. Sun | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2015 | 4,575 | 4,575 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jun 2015 | 1,222 | 35,413 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jun 2015 | 1,375 | 34,038 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jun 2015 | 1,222 | 21,265 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Jun 2015 | 687 | 20,578 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2015 | 2,400 | 12,112 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2015 | 2,400 | 24,887 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Jun 2015 | 2,400 | 22,487 | - | - | Common Stock | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2015 | 309,000 | 309,000 | - | - | Stock Option (Right to Buy) | |
Jay P. Shepard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2015 | 96,000 | 96,000 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2015 | 2,400 | 14,512 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2015 | 2,400 | 24,887 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 May 2015 | 2,400 | 22,487 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Apr 2015 | 8,000 | 121,548 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 359 | 0 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 2,041 | 16,912 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2015 | 2,400 | 24,887 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 06 Apr 2015 | 2,400 | 22,487 | - | - | Common Stock | |
Shane M. Ward | SVP, Legal and Compliance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2015 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Mar 2015 | 4,000 | 93,432 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2015 | 1,124 | 99,487 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2015 | 1,315 | 98,172 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2015 | 740 | 97,432 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Mar 2015 | 80 | 101,352 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Mar 2015 | 3 | 101,349 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Mar 2015 | 738 | 100,611 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Mar 2015 | 1,463 | 103,969 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Mar 2015 | 2,537 | 101,432 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Mar 2015 | 1,129 | 105,432 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2015 | 359 | 359 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2015 | 2,041 | 18,953 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2015 | 2,400 | 24,887 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Mar 2015 | 2,400 | 22,487 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Mar 2015 | 2,871 | 106,561 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 25 Feb 2015 | 8,000 | 109,432 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2015 | 1,499 | 718 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2015 | 3,501 | 20,994 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2015 | 5,000 | 27,487 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Feb 2015 | 4,629 | 22,858 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 03 Feb 2015 | 371 | 22,487 | - | - | Common Stock | |
Andrew N. Schiff | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Jan 2015 | 145,000 | 2,139,568 | - | - | Common Stock | |
R. Scott Greer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Jan 2015 | 5,500 | 10,500 | - | - | Common Stock | |
Anthony Y. Sun | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Jan 2015 | 145,000 | 2,139,568 | - | - | Common Stock | |
Shahzad Malik | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Jan 2015 | 55,000 | 2,271,558 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 12 Jan 2015 | 4,000 | 117,432 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jan 2015 | 200 | 125,232 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Jan 2015 | 3,800 | 121,432 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 24,373 | 24,373 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 10,445 | 36,635 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 75,041 | 75,041 | - | - | Stock Option (Right to Buy) | |
Jeffrey L. Cleland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 32,160 | 129,432 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Dec 2014 | 4,000 | 125,432 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 8,860 | 8,860 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2014 | 3,797 | 22,487 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Dec 2014 | 1,900 | 141,388 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Dec 2014 | 20 | 141,368 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Dec 2014 | 2,110 | 139,258 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Dec 2014 | 5,870 | 133,388 | - | - | Common Stock | |
Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Dec 2014 | 150,000 | 2,409,374 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 15 Dec 2014 | 496 | 142,396 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2014 | 6,946 | 10,271 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2014 | 3,054 | 7,217 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2014 | 6,946 | 25,636 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Dec 2014 | 6,946 | 18,690 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2014 | 3,054 | 21,744 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Dec 2014 | 3,054 | 18,690 | - | - | Common Stock | |
R. Scott Greer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2014 | 35,000 | 35,000 | - | - | Stock Option (right to Buy) | |
Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Nov 2014 | 800,000 | 2,559,374 | - | - | Common Stock | |
Philippe O. Chambon | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Sep 2014 | 12,556 | 3,359,374 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 32,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 15,000 | 25,000 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Jeffrey L. Cleland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 30,000 | 146,280 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2014 | 7,500 | 17,500 | - | - | Common Stock | |
Joshua T. Brumm | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2014 | 10,000 | 10,000 | - | - | Common Stock | |
Jeffrey L. Cleland | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2014 | 10,000 | 116,280 | - | - | Common Stock | |
Paul Westberg | Sr. VP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2014 | 10,000 | 10,000 | - | - | Common Stock | |
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 20,942,466 | 0 | - | - | Series B Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 8,439,620 | 0 | - | - | Series C Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 3,050,019 | 0 | - | - | Series D1 Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 1,349,433 | 0 | - | - | Series D2 Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 3,546,094 | 0 | - | - | Series E Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 759,565 | 0 | - | - | Warrant | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 759,565 | 0 | - | - | Series B Convertible Preferred Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 1,821,084 | 1,821,084 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 733,880 | 2,554,964 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 265,219 | 2,820,183 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 117,342 | 2,937,525 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 308,356 | 3,245,881 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | 27 Mar 2014 | 66,049 | 3,311,930 | - | - | Common Stock | ||
Philippe O. Chambon | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Mar 2014 | 60,000 | 3,371,930 | - | - | Common Stock | |
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 403,704 | 0 | - | - | Series B Convertible Preferred Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 14,222,222 | 0 | - | - | Series C Convertible Preferred Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 1,479,993 | 0 | - | - | Series D-1 Convertible Preferred Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 654,796 | 0 | - | - | Series D-2 Convertible Preferred Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 5,486,820 | 0 | - | - | Series E Convertible Preferred Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 35,104 | 35,104 | - | - | Common Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 1,236,715 | 1,271,819 | - | - | Common Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 128,695 | 1,400,514 | - | - | Common Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 56,939 | 1,457,453 | - | - | Common Stock | ||
Andrew N. Schiff | Ten Percent Owner | 26 Mar 2014 | 477,115 | 1,934,568 | - | - | Common Stock | ||
Andrew N. Schiff | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2014 | 60,000 | 1,994,568 | - | - | Common Stock | |
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 23,403 | 0 | - | - | Series B Convertible Preferred Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 775,315 | 0 | - | - | Series D-1 Convertible Preferred Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 802,596 | 0 | - | - | Series D-2 Convertible Preferred Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 485,664 | 0 | - | - | Series E Convertible Preferred Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 23,403 | 23,403 | - | - | Common Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 775,315 | 798,718 | - | - | Common Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 802,596 | 1,601,314 | - | - | Common Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | 26 Mar 2014 | 485,664 | 2,086,978 | - | - | Common Stock | ||
Srinivas Akkaraju | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2014 | 60,000 | 2,146,978 | - | - | Common Stock | |
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 506,376 | 0 | - | - | Warrants to Purchase Series B Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 506,376 | 14,468,020 | - | - | Series B Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 14,468,020 | 0 | - | - | Series B Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 5,626,413 | 0 | - | - | Series C Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 2,033,350 | 0 | - | - | Series D-1 Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 899,619 | 0 | - | - | Series D-2 Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 1,773,049 | 0 | - | - | Series E Convertible Preferred Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 1,258,086 | 1,258,086 | - | - | Common Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 489,253 | 1,747,339 | - | - | Common Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 176,813 | 1,924,152 | - | - | Common Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 78,228 | 2,002,380 | - | - | Common Stock | ||
Shahzad Malik | Director, Ten Percent Owner | 26 Mar 2014 | 154,178 | 2,156,558 | - | - | Common Stock | ||
Shahzad Malik | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2014 | 60,000 | 2,216,558 | - | - | Common Stock | |
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 403,704 | 0 | - | - | Series B Convertible Preferred Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 14,222,222 | 0 | - | - | Series C Convertible Preferred Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 1,479,993 | 0 | - | - | Series D-1 Convertible Preferred Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 654,796 | 0 | - | - | Series D-2 Convertible Preferred Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 5,486,820 | 0 | - | - | Series E Convertible Preferred Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 35,104 | 35,104 | - | - | Common Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 1,236,715 | 1,271,819 | - | - | Common Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 128,695 | 1,400,514 | - | - | Common Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 56,939 | 1,457,453 | - | - | Common Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | 26 Mar 2014 | 477,115 | 1,934,568 | - | - | Common Stock | ||
Anthony Y. Sun | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Mar 2014 | 60,000 | 1,994,568 | - | - | Common Stock | |
Srinivas Akkaraju | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2014 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Edmon Jennings | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2014 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
Shahzad Malik | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2014 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
John Varian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2014 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) |